109 related articles for article (PubMed ID: 21240070)
1. Pulmonary haptoglobin: a new marker for adenocarcinomas of the lung?
Abdullah M; Marwitz S; Kähler D; Schultz H; Kugler C; Zabel P; Vollmer E; Goldmann T
Pathology; 2011 Jan; 43(1):70-2. PubMed ID: 21240070
[No Abstract] [Full Text] [Related]
2. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
3. Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas.
Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Shinichiro R; Masuda N; Goshima N; Jiang SX; Okayasu I
Lung Cancer; 2010 Jul; 69(1):54-9. PubMed ID: 19892429
[TBL] [Abstract][Full Text] [Related]
4. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
[TBL] [Abstract][Full Text] [Related]
5. TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.
Fatima N; Cohen C; Lawson D; Siddiqui MT
Cancer Cytopathol; 2011 Apr; 119(2):127-33. PubMed ID: 21287692
[TBL] [Abstract][Full Text] [Related]
6. Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?
Deniz H; Kibar Y; Güldür ME; Bakir K
Pathol Res Pract; 2009; 205(11):749-52. PubMed ID: 19573998
[TBL] [Abstract][Full Text] [Related]
7. Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues.
Abdullah M; Schultz H; Kähler D; Branscheid D; Dalhoff K; Zabel P; Vollmer E; Goldmann T
Pathol Res Pract; 2009; 205(9):639-47. PubMed ID: 19501987
[TBL] [Abstract][Full Text] [Related]
8. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
[TBL] [Abstract][Full Text] [Related]
9. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling.
Santonico M; Lucantoni G; Pennazza G; Capuano R; Galluccio G; Roscioni C; La Delfa G; Consoli D; Martinelli E; Paolesse R; Di Natale C; D'Amico A
Lung Cancer; 2012 Jul; 77(1):46-50. PubMed ID: 22264635
[TBL] [Abstract][Full Text] [Related]
10. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
Uke M; Rekhi B; Ajit D; Jambhekar NA
Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics.
Sterlacci W; Tzankov A; Veits L; Oberaigner W; Schmid T; Hilbe W; Fiegl M
Am J Clin Pathol; 2011 Apr; 135(4):611-8. PubMed ID: 21411784
[TBL] [Abstract][Full Text] [Related]
12. CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.
Shinmura K; Igarashi H; Kato H; Kawanishi Y; Inoue Y; Nakamura S; Ogawa H; Yamashita T; Kawase A; Funai K; Sugimura H
Dis Markers; 2014; 2014():619273. PubMed ID: 25548429
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study on neuron specific enolase (NSE) as a tumor marker in primary lung cancer].
Suzuki K; Reshad K; Takahashi Y; Morita H; Hirata T; Itoi K; Nakano Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jun; 25(6):625-31. PubMed ID: 2824900
[No Abstract] [Full Text] [Related]
14. Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas.
Camilo R; Capelozzi VL; Siqueira SA; Del Carlo Bernardi F
Hum Pathol; 2006 May; 37(5):542-6. PubMed ID: 16647951
[TBL] [Abstract][Full Text] [Related]
15. miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.
Del Vescovo V; Cantaloni C; Cucino A; Girlando S; Silvestri M; Bragantini E; Fasanella S; Cuorvo LV; Palma PD; Rossi G; Papotti M; Pelosi G; Graziano P; Cavazza A; Denti MA; Barbareschi M
Am J Surg Pathol; 2011 Feb; 35(2):268-75. PubMed ID: 21263248
[TBL] [Abstract][Full Text] [Related]
16. [PCNA (proliferating cell nuclear antigen) expression in adenocarcinomas < 2 cm of the peripheral lung].
Koshikawa T; Nakamura S; Kitoh K; Hayashi K; Suyama M; Kunishima K
Rinsho Byori; 1993 Jun; Suppl 94():113-24. PubMed ID: 8103122
[No Abstract] [Full Text] [Related]
17. Interobserver agreement and assay reproducibility of folate receptor α expression in lung adenocarcinoma: a prognostic marker and potential therapeutic target.
Bremer RE; Scoggin TS; Somers EB; O'Shannessy DJ; Tacha DE
Arch Pathol Lab Med; 2013 Dec; 137(12):1747-52. PubMed ID: 23570254
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
19. [Transbronchial biopsy of the lung in the diagnosis of peripheral cancer and diffuse-disseminated processes].
Lebedev VA; Blinchevskiĭ ID
Sov Med; 1990; (9):107-11. PubMed ID: 2176348
[No Abstract] [Full Text] [Related]
20. Erythrocyte fatty acids as potential biomarkers in the diagnosis of advanced lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung cancer.
de Castro J; Rodríguez MC; Martínez-Zorzano VS; Sánchez-Rodríguez P; Sánchez-Yagüe J
Am J Clin Pathol; 2014 Jul; 142(1):111-20. PubMed ID: 24926094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
